CDKN2A and mesothelioma: Genetic analyses identified several key genetic alterations in end-stage disease, with most common deletions or mutations in CDKN2A, NF2, and BAP1 genes [4], and suggested that two main pathways, p53/DNA repair and PI3K-AKT, were associated with mesothelioma progression [5].